Article

HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome

2022-02-21

Abstract excerpt

<title>Abstract</title> <p>Purpose Apocrine carcinoma of the breast (APO) expresses HER2 in 30-50% of cases. This study explored the clinicopathological features and outcome of HER2+/APO and matched HER2+/NST cohort. Methods We used the SEER database to explore the cohorts. Univariate and multivariate analyses were used to assess the survival. Based on ER and PR [=HR] and HER2 status, we divided the cohorts to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 25f7d2aa-64de-568f-80fd-d7d51a2cdecd
DOI: 10.21203/rs.3.rs-1280152/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and OutcomeDOI 10.21203/rs.3.rs-1280152/v2Read

Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.Semantic proximity Read

PIK3CA mutation in ER-negative and HER2-positive breast cancer with apocrine differentiation.Semantic proximity Read

Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.Semantic proximity Read

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.Semantic proximity Read

The development of Breast Apocrine Carcinoma (BAC) score that distinguishes breast and cutaneous apocrine carcinomasSemantic proximity Read

Neoadjuvant Chemotherapy Response in Triple-Negative Apocrine Carcinoma: Comparing Apocrine Morphology, Androgen Receptor, and Immune Phenotypes.Semantic proximity Read

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.Semantic proximity Read

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other BiomarkersSemantic proximity Read

Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological modelSemantic proximity Read

Identification of molecular apocrine breast tumours by microarray analysis.Semantic proximity Read

Estrogen Receptor-negative/progesterone Receptor-positive and Her-2 Negative Breast Cancer Might No Longer Be Classified as Hormone Receptor Positive Breast CancerSemantic proximity Read

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1Semantic proximity Read